bpc-157 fda category 2 compounding Legit — Audit of the Body Protection Compound 157 Research Record BREAKING: The FDA just reversed
Description
Some patients may experience slight soreness at the injection site or minor bruising, which typically resolves within 24-48 hours
Always adhere to established lab safety protocols
Lower concentration, larger draw volume per dose
Temporary injection-site pain, redness, warmth, nausea, dizziness, headache, or rash may occur
